China
Top Ten most popular articles on Pharmafile.com this week
February 22, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cancer, China, MedImmune, Xeljanz, asthma, diabetes, keytruda, osteoarthritis, pharma, rare disease
Happy Friday! With the weekend within reach, check out our run-down of the top ten most popular articles on Pharmafile.com …
China to establish national rare disease network
February 19, 2019Manufacturing and Production China, NHC, healthcare, rare diseases
China is set to establish a national collaborative network of hospitals for rare disease diagnosis and treatment to promote early …
China’s NMPA approves Amgen’s Repatha to reduce cardiovascular event risk
January 25, 2019Medical Communications, Sales and Marketing Amgen, China, Repatha, cardiovascular disease, pharma, stroke
Amgen has announced that its proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor Repatha (evolocumab) has secured approval by China’s drug …
Boehringer expands manufacturing facility in Shanghai
January 22, 2019Manufacturing and Production Boehringer Ingelheim, China, Shanghai, facilities, manufacturing, pharma
German firm Boehringer Ingelheim has expanded the capacity of its commercial manufacturing site for biologics in Shanghai, China. The expansion …
Scientist who genetically modified babies faces punishment after acting illegally, Chinese authorities confirm
January 22, 2019Manufacturing and Production China, He Jiankui, crispr, ethics, gene editing
Chinese state media have confirmed that He Jiankui, the scientist who claimed to have genetically modified babies to prevent them …
China becomes first country to approve roxadustat in chronic kidney disease
December 19, 2018Research and Development, Sales and Marketing AstraZeneca, China, chronic kidney disease, pharma
AstraZeneca has announced that its partner Fibrogen has secured the first national approval for its hypoxia-inducible factor prolyl hydroxylase inhibitor …
Guangdong bans transportation of pigs due to African swine fever outbreak in Hunan
October 23, 2018Research and Development ASF, African swine fever, China, Guangdong, Hunan, animal health
Chinese authorities have banned the transportation of live pigs from Guangdong to other regions, after reports of African swine fever …
Novo Nordisk cuts 650 roles around the world in R&D restructure
October 1, 2018Manufacturing and Production, Sales and Marketing China, Denmark, Novo Nordisk, UK, US, pharma
Novo Nordisk has announced a wave of jobs cuts as part of a global restructure of its $1 billion R&D …
Novartis strike $40m deal with Chinese firm Cellular Biomedicine
September 28, 2018Medical Communications CAR T, CAR-T, China, Kymriah, Novartis, cellular biomedicine, prc
Swiss multinational Novartis have paired up with Chinese drugmaker Cellular Biomedicine (CBMG) in order to manufacture CAR-T therapy Kymriah in …
MSD to launch Keytruda at half US list price in China
September 20, 2018Business Services, Sales and Marketing BMS, China, MSD, global, keytruda, markets, pricing
US pharma giant MSD will offer cutting edge cancer treatment Keytruda to Chinese patients at half the price at what …
AstraZeneca to increase presence in China
September 19, 2018Research and Development AstraZeneca, China, alibaba, governemnt, tencent
The Anglo-Swedish multinational AstraZeneca is moving towards becoming a major healthcare provider in China as part of an effort to …
Further six officials fired from China FDA
August 21, 2018Manufacturing and Production CFDA, Changsheng biotechnology, China, Vaccine, scandal
A further six senior officials from the China Food and Drug Administration (CFDA) have been fired in relation to the …
Thyroid medication recalled after Chinese supplier fails inspection
August 20, 2018Sales and Marketing China, FDA, recall, thyroid, westminster
The Mississippi based manufacturer Westminster Pharmaceuticals is voluntarily recalling thyroid medications Levothyroxine and Liothyronine after the Chinese company Sichuan Friendly …
Chinese regulators approve Roche’s Alecensa in regulatory shift
August 20, 2018Sales and Marketing Cancer, China, Roche, approval, lung cancer
China’s National Drug Administration has granted rapid approval for Roche’s lung cancer treatment Alecensa (alectinib). Chinese regulators have in the …
CCP fire provincial official and investigate drug regulator in response to Changsheng vaccine scandal
August 17, 2018Medical Communications China, Vaccine, changsheng, drug safety, regulation
The Chinese government has fired a senior provincial official and is probing a former senior drug regulator in response to …
